Additional poster presentations highlight Vafseo® (vadadustat) clinical and economic dataWALTHAM, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the ...
Eli Lilly and Company (NYSE: LLY) will present new data across its dermatology portfolio at the 2026 Fall Clinical Dermatology ...
Background Heart failure (HF) remains associated with high mortality worldwide despite advances in guideline-directed therapy ...
Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a biopharmaceutical company focused on developing medicines to target hypertension and ...
RINVOQ is the first and only systemic medication approved in the European Union to treat adult and adolescent patients with non-segmental vitiligo (NSV) who are candidates for systemic therapy Phase 3 ...
Cardiovascular disease remains the leading cause of death across European Society of Cardiology (ESC) member countries. Yet ...
Alexion, AstraZeneca Rare Disease, will advance its ambition to transform outcomes for people living with generalised myasthenia gravis (gMG) across ...
New long-term data will further substantiate potential of gefurulimab as once-weekly subcutaneous self-administered treatment for adults with gMG Additional data will showcase commitment to advancing ...
Research in The Milbank Quarterly reveals that for decades, US mortality rates have exceeded rates in peer countries and have been increasing across many causes of death, especially in young adults ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. The global AI race is creating a stark divide in data center reception. While countries like ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results